China Universal Asset Management »

C4 Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $28k 13k 2.22
2025-06-30 $20k 14k 1.43
2025-03-31 $23k 14k 1.60
2024-12-31 $54k 15k 3.60
2023-09-30 $2.4k 1.3k 1.86
2023-06-30 $1.8k 643 2.75
2023-03-31 $2.1k 665 3.14
2022-12-31 $2.9k 497 5.90
2022-09-30 $4.0k 458 8.73

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Alphabet Inc-cl A Common Stock (GOOGL)
Meta Platforms Inc-class A Common Stock (META)
Netflix Common Stock (NFLX)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Gilead Sciences Common Stock (GILD)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl C Common Stock (GOOG)
Palantir Technologies Inc-a Common Stock (PLTR)
Applovin Corp-class A Common Stock (APP)

View all positions for China Universal Asset Management

Top funds holding C4 Therapeutics

Lynx1 Capital Management
Soleus Capital Management
OrbiMed Advisors
Daniel D. Thurber
Morgan Stanley
Vanguard Group
Millennium Management
Silverarc Capital Management
BlackRock
Bain Capital Life Sciences Investors
Renaissance Technologies
Tang Capital Management
Two Sigma Investments
Two Sigma Advisers
Geode Capital Management

View all funds holding C4 Therapeutics